NEWPORT BEACH, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it is resuming negotiations to establish a location in Los Angeles to package and distribute Amster-Can products. The company also announced a new partnership that will allow Advantis to work under the umbrella of a statewide distribution license. The details of the partnership include Amster-Can packaging and distribution, and a mutual manufacturing and distribution agreement.
The company announced early last year that it was looking at establishing its Southern California presence more centrally in Orange County and Los Angeles. Advantis has provided updates about finalizing plans and licensing for its Orange County operation, but this is the first update about progress with the Los Angeles location. “Controlled growth,” Advantis CEO, Darren Cherry explained. “When we first started moving forward, we found that the time and expense prohibited us from doing both locations at the same time. We started and have our biggest client base here in Orange County, so we naturally expand here to have a location that more efficiently serves our core and mobile clients.” Cherry pivoted to what he said was the company’s greater goal. “The reason to expand in Los Angeles is entirely different and much more exciting to talk about.”
Cherry says that he would expect Amster-Can revenue to immediately double upon establishing a fully licensed location in Los Angeles, or he wouldn’t be doing it. “The recent revenue increase we’ve experienced is enabling us to focus some time on expanding our business more aggressively.” Cherry said. “We have clients we serve now that want us to be in Los Angeles so they can be more efficient and feel secure with transportation security; we have just as many prospects that want us there for the same reasons. If we were open there now, our global Amster-Can production would most assuredly double immediately. This being said, we have to establish a facility in Los Angeles that will allow us to produce for their needs as well as a hundred times more than that capacity to serve this kind of exponential growth,” Cherry related. “This is what will help make us a billion-dollar company, along with my next announcement.”
Advantis has made several marketing and distribution agreements over the years, but Cherry seems most excited to announce this one. Cherry says he has formed a partnership with a global manufacturing and distribution company that is fully licensed for both within the state of California. “This partnership will create synergy for both of our companies,” Cherry claims. “They want Advantis to package their product lines in Amster-Cans, and we will be one of many companies under their distribution license, which allows us to expand our reach in this great state. We will increase Amster-Can production immediately to package their products, and they will market our products through their distribution partners. It’s a win-win, and I love that.” Cherry concluded, “Putting this deal together comes at a perfect time as we complete testing of our proprietary CBD gummies, balm, lotion, and pills this summer. It’s an instant massive distribution channel.”
Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.
Links to Advantis websites can be found at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com
About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.